Therapie von Lungenfibrosen bei rheumatischen Systemerkrankungen (neue Therapien)

An interstitial lung disease represents a relevant organ manifestation in many systemic rheumatic diseases (connective tissue disease-interstitial lung disease, CTD-ILD). In 10% of the cases pulmonary fibrosis even results in an underlying systemic disease. The CTD-ILDs are frequently associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Buschulte, Katharina, Hoffmann-Vold, Anna-Maria, Dobrota, Rucsandra, Höger, Philipp, Krause, Andreas, Kreuter, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
CME
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429885/
https://www.ncbi.nlm.nih.gov/pubmed/34505934
http://dx.doi.org/10.1007/s00393-021-01067-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429885/
https://www.ncbi.nlm.nih.gov/pubmed/34505934
http://dx.doi.org/10.1007/s00393-021-01067-3

Ejemplares similares